Obsessive-Compulsive Disorder With Rheumatological and Inflammatory Diseases: A Systematic Review
- PMID: 33954077
- PMCID: PMC8088283
- DOI: 10.7759/cureus.14791
Obsessive-Compulsive Disorder With Rheumatological and Inflammatory Diseases: A Systematic Review
Abstract
Obsessive-compulsive disorder (OCD) is a common mental illness that can significantly impair the patients' quality of life. Recent studies have shown that patients with this condition usually suffer from inflammatory or rheumatological comorbidities. However, the association between OCD's etiology and inflammation is still controversial. This review aims to explore the correlation between OCD and rheumatological as well as inflammatory disorders based on studies conducted in the last decade. A total of eight articles that were deemed eligible were included in the final assessment, involving 31,204 OCD patients from various countries. The most significant inflammatory biomarkers examined were tumor necrosis factor-alpha (TNF-α), interleukins, neutrophil-to-lymphocyte ratio (NLR), and cytokines. We concluded that the pathophysiology and etiology of OCD are strongly correlated with inflammatory biomarkers. This finding warrants future studies on the efficacy of anti-inflammatory agents to treat OCD, particularly in the early stages of the disease.
Keywords: association; biomarkers; inflammation; obsessive-compulsive disorders; rheumatology; systematic review.
Copyright © 2021, Alsheikh et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in adolescent obsessive-compulsive disorder: does comorbid anxiety disorder affect inflammatory response? Özyurt G, Binici NC. Psychiatry Res. 2019;272:311–315. - PubMed
-
- Anti-inflammatory augmentation therapy in obsessive-compulsive disorder: a review. Ghasemi H, Nomani H, Sahebkar A, Mohammadpour AH. Lett Drug Des Discov. 2020;17:1198–1205.
-
- Obsessive-compulsive disorder: autoimmunity and neuroinflammation. Gerentes M, Pelissolo A, Rajagopal K, Tamouza R, Hamdani N. Curr Psychiatry Rep. 2019;21:78. - PubMed
-
- Psychedelics as anti-inflammatory agents. Flanagan TW, Nichols CD. Int Rev Psychiatry. 2018;30:363–375. - PubMed
-
- Novel inflammatory targets for immunotherapies in pediatric patients with trichotillomania. Kutuk MO, Tufan AE, Kilicaslan F, et al. Immunobiology. 2020;225:151913. - PubMed
Publication types
LinkOut - more resources
Full Text Sources